Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company developing biological therapeutics for degenerative diseases and regenerative medicine. Its principal products include Zofin, derived from amniotic fluid retaining extracellular vesicles, proteins, and cell secreted nanoparticles, and Patient Pure X (PPX), an autologous biologic precipitated from a patient's own peripheral blood. The company also distributes topical aesthetic products incorporating proprietary ingredients. All products are manufactured in FDA-registered, cGMP-compliant facilities in Davie, Florida. The company is pursuing clinical trials and commercial sales strategies aligned with Florida's SB 1768 stem cell therapy law for orthopedic, wound care, and pain management indications.
expected 2027-01-29
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-01-29 | 2025-10-31 | 0001829126-26-000763 | EDGAR | 65K words |
| 2025-01-29 | 2024-10-31 | 0001829126-25-000536 | EDGAR | 58K words |
| 2024-01-29 | 2023-10-31 | 0001829126-24-000541 | EDGAR | 71K words |
| 2023-02-14 | 2022-10-31 | 0001829126-23-001524 | EDGAR | 77K words |
| 2022-02-14 | 2021-10-31 | 0001829126-22-003605 | EDGAR | 75K words |
| 2021-02-08 | 2020-10-31 | 0001829126-21-000414 | EDGAR | 64K words |
| 2020-10-16 | 2019-10-31 | 0001683168-20-003466 | EDGAR | 84K words |
| 2020-03-06 | 2018-10-31 | 0001683168-20-000712 | EDGAR | 98K words |
| 2018-11-01 | 2017-10-31 | 0001683168-18-003206 | EDGAR | 95K words |
| 2017-07-07 | 2016-10-31 | 0001493152-17-007610 | EDGAR | 83K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2026-01-31 | 0001829126-26-002396 | EDGAR | 17K words |
| 2025-09-15 | 2025-07-31 | 0001829126-25-007398 | EDGAR | 21K words |
| 2025-06-16 | 2025-04-30 | 0001829126-25-004512 | EDGAR | 19K words |
| 2025-03-17 | 2025-01-31 | 0001829126-25-001828 | EDGAR | 15K words |
| 2024-09-16 | 2024-07-31 | 0001829126-24-006296 | EDGAR | 19K words |
| 2024-06-14 | 2024-04-30 | 0001829126-24-004217 | EDGAR | 17K words |
| 2024-03-18 | 2024-01-31 | 0001829126-24-001677 | EDGAR | 14K words |
| 2023-09-14 | 2023-07-31 | 0001829126-23-006098 | EDGAR | 24K words |
| 2023-06-16 | 2023-04-30 | 0001829126-23-004245 | EDGAR | 23K words |
| 2023-03-17 | 2023-01-31 | 0001829126-23-002113 | EDGAR | 18K words |
| 2022-09-14 | 2022-07-31 | 0001829126-22-016867 | EDGAR | 27K words |
| 2022-06-14 | 2022-04-30 | 0001829126-22-013532 | EDGAR | 21K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-03 | 0001829126-26-011913 | EDGAR | 2K words |
| 2026-10-30 | 0001829126-26-011800 | EDGAR | 27K words |
| 2026-10-26 | 0001829126-26-011497 | EDGAR | 1K words |
| 2026-09-15 | 0001829126-26-010100 | EDGAR | 1K words |
| 2026-09-15 | 0001829126-26-010114 | EDGAR | 1K words |
| 2026-09-01 | 0001829126-26-009583 | EDGAR | 1K words |
| 2026-08-04 | 0001829126-26-008299 | EDGAR | 1K words |
| 2026-07-21 | 0001829126-26-007689 | EDGAR | 1K words |
| 2026-03-31 | 0001829126-26-002881 | EDGAR | 1K words |
| 2026-03-27 | 0001829126-26-002789 | EDGAR | 0K words |
211 total filings indexed. 179 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001557376 |
| Ticker | ZEOX |
| Exchange | OTC |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | NV |
| Headquarters | Davie, Florida |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ZEOX (~200 tokens, structured JSON with cryptographic provenance)